Immatics at the FDA/CDER-HESI Workshop (Oct 1-2) in Silver Spring, MD

| News, USA

Meet Frank Schwöbel, Ass. Director Translational Development at Immatics, at the FDA/CDER-HESI Workshop in Silver Spring, Maryland (Oct 1-2) and hear him talk:


October 1st, 1:15pm-4:35pm

"Preclinical evaluation of TCR bispecifics targeting cancer-specific HLA ligands in the absence of relevant animal models"

Speaker: Frank Schwöbel (Ass. Director Translational Development)

Session: "In vivo pharmacology and toxicology"


We're looking forward to interesting and exciting discussions.

Further information on HESI here.

Press Contact

Anja Heuer

Corporate Communications,
Immatics Biotechnologies GmbH

+49 89 540 415 606

Go back

We use cookies to ensure that we give you the best experience on our website.